PDB94 - INITIAL ANTIDIABETIC PHARMACOTHERAPY PRESCRIBED TO PATIENTS WITH NEWLY DIAGNOSED TYPE-2 DIABETES IN A COMMERCIAL HEALTH PLAN IN THE UNITED STATED
Abstract
Authors
H.A. Althobaiti M.Y. Alsheikh E. Seoane-Vazquez J. Lewis L.M. Brown